This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 Jan 1;183(1):7-11.

doi: 10.1084/jem.183.1.7.

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

J W Young¹, K Inaba

Affiliations

PMID: 8551246
PMCID: PMC2192420
DOI: 10.1084/jem.183.1.7

Comment

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

J W Young et al. J Exp Med. 1996.

. 1996 Jan 1;183(1):7-11.

doi: 10.1084/jem.183.1.7.

Authors

J W Young¹, K Inaba

Affiliation

¹ Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021, USA.

PMID: 8551246
PMCID: PMC2192420
DOI: 10.1084/jem.183.1.7

No abstract available

PubMed Disclaimer

Comment on

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr. Celluzzi CM, et al. J Exp Med. 1996 Jan 1;183(1):283-7. doi: 10.1084/jem.183.1.283. J Exp Med. 1996. PMID: 8551233 Free PMC article.
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Paglia P, et al. J Exp Med. 1996 Jan 1;183(1):317-22. doi: 10.1084/jem.183.1.317. J Exp Med. 1996. PMID: 8551239 Free PMC article.
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Zitvogel L, et al. J Exp Med. 1996 Jan 1;183(1):87-97. doi: 10.1084/jem.183.1.87. J Exp Med. 1996. PMID: 8551248 Free PMC article.

Similar articles

Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines.
Grohmann U, Bianchi R, Belladonna ML, Silla S, Surace D, Fioretti MC, Puccetti P. Grohmann U, et al. Adv Exp Med Biol. 1997;417:579-82. doi: 10.1007/978-1-4757-9966-8_93. Adv Exp Med Biol. 1997. PMID: 9286421 No abstract available.
Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
Han HD, Byeon Y, Kang TH, Jung ID, Lee JW, Shin BC, Lee YJ, Sood AK, Park YM. Han HD, et al. Int J Nanomedicine. 2016 Nov 2;11:5729-5742. doi: 10.2147/IJN.S109001. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27843314 Free PMC article.
Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
Rawson P, Hermans IF, Huck SP, Roberts JM, Pircher H, Ronchese F. Rawson P, et al. Cancer Res. 2000 Aug 15;60(16):4493-8. Cancer Res. 2000. PMID: 10969797
gp96--the immune system's Swiss army knife.
Schild H, Rammensee HG. Schild H, et al. Nat Immunol. 2000 Aug;1(2):100-1. doi: 10.1038/77770. Nat Immunol. 2000. PMID: 11248798 Review. No abstract available.
[Antitumor cellular immunotherapy: the breakthrough of dendritic cells].
Angevin E, André F, Zitvogel L. Angevin E, et al. Bull Cancer. 2000 Jan;87(1):107-15. Bull Cancer. 2000. PMID: 10673639 Review. French. No abstract available.

See all similar articles

Cited by

Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X, Zhang W, Wang J, Zhang M, Huang X, Hamada H, Chen W. Cao X, et al. Immunology. 1999 Aug;97(4):616-25. doi: 10.1046/j.1365-2567.1999.00823.x. Immunology. 1999. PMID: 10457215 Free PMC article.
Expression of MHC and adhesion/costimulation molecules of dendritic cells from human blood during their differentiation in vitro.
Chiriva-Internati M, Grizzi F, Orbetegli O, Lim S, Hermonat PL, Dioguardi N. Chiriva-Internati M, et al. In Vitro Cell Dev Biol Anim. 2001 Mar;37(3):177-9. doi: 10.1290/1071-2690(2001)037<0177:EOMAAC>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2001. PMID: 11370811 No abstract available.
Dendritic cells as adjuvants for immune-mediated resistance to tumors.
Schuler G, Steinman RM. Schuler G, et al. J Exp Med. 1997 Oct 20;186(8):1183-7. doi: 10.1084/jem.186.8.1183. J Exp Med. 1997. PMID: 9379142 Free PMC article. Review. No abstract available.
In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
Dow SW, Elmslie RE, Willson AP, Roche L, Gorman C, Potter TA. Dow SW, et al. J Clin Invest. 1998 Jun 1;101(11):2406-14. doi: 10.1172/JCI510. J Clin Invest. 1998. PMID: 9616212 Free PMC article.
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Fanger NA, et al. J Exp Med. 1999 Oct 18;190(8):1155-64. doi: 10.1084/jem.190.8.1155. J Exp Med. 1999. PMID: 10523613 Free PMC article.

See all "Cited by" articles

References

1. Eur J Immunol. 1988 Feb;18(2):219-23 - PubMed
1. J Exp Med. 1994 Apr 1;179(4):1109-18 - PubMed
1. J Clin Invest. 1990 Mar;85(3):955-61 - PubMed
1. J Exp Med. 1990 Apr 1;171(4):1315-32 - PubMed
1. J Exp Med. 1990 Aug 1;172(2):631-40 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database